PEDEVCO CORP. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PEDEVCO Corp. on April 13, 2016, regarding events occurring on April 7, 2016. The filing details a material definitive agreement entered into with the Company's lenders to extend a payment deferral arrangement.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or liquidity figures. The report focuses exclusively on debt service obligations under existing Senior Secured Promissory Notes and a Junior Note. No new debt issuance or financial statement data is presented in this document.
Material Changes
The primary material change is the extension of a payment deferral agreement. On April 7, 2016, the Company entered into a Letter Agreement with its lenders (including Senior Health Insurance Company of Pennsylvania and RJ Credit LLC) to extend the deferral of principal and interest payments through April 30, 2016. This follows previous deferral agreements dated August 28, 2015, January 29, 2016, and March 7, 2016.
Outlook, Risks, and Unusual Items
- Deferral Extension: Mandatory principal payments due through April 30, 2016, are deferred until the maturity date of the Senior Notes.
- Interest Capitalization: All interest payments due in April 2016 are deferred and will be added to the principal balance on the first business day of the following month.
- Warrant Issuance: The issuance of "Subsequent Warrants" required under the original deferral agreements is delayed until within 30 days of May 1, 2016, contingent upon NYSE MKT additional listing approval.
- Risk: The continued need for payment deferrals indicates ongoing liquidity constraints and reliance on lender forbearance.
Investor Verification Checklist
- Verify the total outstanding principal and accrued interest amounts on the Senior Notes and RJC Junior Note as of April 30, 2016.
- Confirm the specific maturity dates of the Senior Notes to understand the timeline for the deferred principal payments.
- Review the terms of the "Subsequent Warrants" to assess potential future dilution once the issuance window opens in May 2016.
- Check for any subsequent filings regarding the NYSE MKT listing approval required for the warrant issuance.
- Examine the Company's most recent 10-Q or 10-K for updated liquidity positions and cash flow statements not included in this 8-K.